[IMCAS Asia 2026 Special ⑱ | Interview] "PRX-PLUS Is a Perfect Fit for This Congress" — Noemi Mancuso, APAC Area Manager, WiQo
As regenerative treatments, biostimulation, and skin quality have become defining priorities in medical aesthetics, attention is increasingly shifting beyond minimally invasive procedures to fully non-invasive approaches. At IMCAS Asia 2026 in Bangkok, we sat down with Noemi Mancuso, Area Manager for the APAC market at Italian medical aesthetics company WiQo. The product she highlighted, PRX-PLUS, is a needle-free, topically applied skin booster — the latest addition to the "topical biostimulator" category pioneered by WiQo. She named three points of differentiation: a specialized formulation designed to act without causing visible peeling or surface disruption, protocols the company says are clinically validated, and a clear focus on skin quality — one of the defining priorities in aesthetics today. She also weighed in on the Asian market, including Korea; described Korean companies as both competitors and attractive partners; and shared her view that the center of gravity in global medical aesthetics is shifting toward Asia.
#MedicalAestheticNews #WiQo #PRXPLUS #IMCASAsia2026
★ Article Link: https://www.medicalaestheticnews.com/news/articleView.html?idxno=20119

Comments
Post a Comment